v3.26.1
STOCKHOLDERS’ EQUITY
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 6— STOCKHOLDERS’ EQUITY

 

SHARES TO BE ISSUED

 

As of March 31, 2026, and 2025, there were 3,617,696 and 3,076,871 shares to be issued, respectively, whose issuance has been deferred under the terms of employment and consulting agreements with officers and directors and other employees of Milestone Scientific. Such shares will be issued to each party upon termination of their employment or other relationship with the Company.

 

As of March 31, 2026 and 2025 there were 1,002,162 and 631,792 respectively, shares to be issued to non-employees, that will be issued to non-employees for services rendered. The number of shares was fixed by contract prior to the date of grant, subject to performance, and were fully earned upon the grant date.

 

The following table summarizes information about shares to be issued for the three month periods ending March 31, 2026 and 2025.

 

SCHEDULE OF SHARES TO BE ISSUED

   March 31, 2026   March 31, 2025 
         
Shares-to-be-issued, outstanding January 1, 2026 and 2025, respectively   4,449,403    3,393,017 
Granted in current period   170,455    315,646 
Issued in current period   -    -
Shares-to be issued outstanding March 31, 2026 and 2025, respectively   4,619,858    3,708,663